GDRX
GoodRx Holdings, Inc.
Medical - Healthcare Information Services
Market Cap$973M
5Y Perf.-94.9%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
GDRX vs OPRX
Revenue, margins, valuation, and 5-year total return — side by side.
OPRX
OptimizeRx Corporation
Medical - Healthcare Information Services
Market Cap$124M
5Y Perf.-68.2%
GDRX vs OPRX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | GDRX | OPRX |
|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Healthcare Information Services |
| Market Cap | $973M | $124M |
| Revenue (TTM) | $788M | $109M |
| Net Income (TTM) | $29M | $5M |
| Gross Margin | 81.0% | 67.3% |
| Operating Margin | 12.4% | 10.7% |
| Forward P/E | 9.0x | 7.0x |
| Total Debt | $60M | $5M |
| Cash & Equiv. | $262M | $23M |
GDRX vs OPRX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
GDRX
OPRX
| Stock | Sep 20 | May 26 | Return |
|---|---|---|---|
| GoodRx Holdings, In… (GDRX) | 100 | 5.1 | -94.9% |
| OptimizeRx Corporat… (OPRX) | 100 | 31.8 | -68.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GDRX vs OPRX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: OPRX leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. GoodRx Holdings, Inc. is the stronger pick specifically for capital preservation and lower volatility and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
GDRX
GoodRx Holdings, Inc.
The Income Pick
GDRX is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 1.58
- Lower volatility, beta 1.58, Low D/E 9.7%, current ratio 2.61x
- Beta 1.58, current ratio 2.61x
Best for: income & stability and sleep-well-at-night
OPRX
OptimizeRx Corporation
The Growth Play
OPRX carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 18.8%, EPS growth 124.5%, 3Y rev CAGR 20.6%
- 110.5% 10Y total return vs GDRX's -94.4%
- 18.8% revenue growth vs GDRX's 0.6%
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | OPRX | 18.8% revenue growth vs GDRX's 0.6% |
| Value | OPRX | Lower P/E (7.0x vs 9.0x) |
| Quality / Margins | OPRX | 4.7% margin vs GDRX's 3.7% |
| Stability / Safety | GDRX | Beta 1.58 vs OPRX's 2.28 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | GDRX | -25.1% vs OPRX's -30.1% |
| Efficiency (ROA) | OPRX | 3.0% ROA vs GDRX's 1.9%, ROIC 7.1% vs 13.0% |
GDRX vs OPRX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
Segment breakdown not available.
GDRX vs OPRX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLGDRXLAGGINGOPRX
OPRXOptimizeRx Corporation
1leads
GDRXGoodRx Holdings, Inc.
4leads
6 Total Categories
CATEGORYLEADERvs OPRXMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
GDRX3/5
Valuation MetricsMultiples, price ratios, and targets
OPRX4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
GDRX5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
GDRX4/6
Risk & VolatilityBeta, volatility, and downside exposure
GDRX2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
GDRX leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
GDRX is the larger business by revenue, generating $788M annually — 7.2x OPRX's $109M. Profitability is closely matched — net margins range from 4.7% (OPRX) to 3.7% (GDRX). On growth, OPRX holds the edge at -0.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | GDRXGoodRx Holdings, … | OPRXOptimizeRx Corpor… |
|---|---|---|
| RevenueTrailing 12 months | $788M | $109M |
| EBITDAEarnings before interest/tax | $184M | $16M |
| Net IncomeAfter-tax profit | $29M | $5M |
| Free Cash FlowCash after capex | $132M | $12M |
| Gross MarginGross profit ÷ Revenue | +81.0% | +67.3% |
| Operating MarginEBIT ÷ Revenue | +12.4% | +10.7% |
| Net MarginNet income ÷ Revenue | +3.7% | +4.7% |
| FCF MarginFCF ÷ Revenue | +16.7% | +10.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.4% | -0.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -1.3% | — |
GDRX leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
OPRX leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 24.6x trailing earnings, OPRX trades at a 26% valuation discount to GDRX's 33.3x P/E. On an enterprise value basis, GDRX's 4.0x EV/EBITDA is more attractive than OPRX's 6.5x.
| Metric | GDRXGoodRx Holdings, … | OPRXOptimizeRx Corpor… |
|---|---|---|
| Market CapShares × price | $973M | $124M |
| Enterprise ValueMkt cap + debt − cash | $771M | $105M |
| Trailing P/EPrice ÷ TTM EPS | 33.29x | 24.56x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.98x | 7.04x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 4.01x | 6.55x |
| Price / SalesMarket cap ÷ Revenue | 1.22x | 1.13x |
| Price / BookPrice ÷ Book value/share | 1.65x | 0.98x |
| Price / FCFMarket cap ÷ FCF | 5.92x | 6.62x |
OPRX leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
GDRX leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GDRX delivers a 4.8% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $4 for OPRX. OPRX carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to GDRX's 0.10x. On the Piotroski fundamental quality scale (0–9), OPRX scores 8/9 vs GDRX's 6/9, reflecting strong financial health.
| Metric | GDRXGoodRx Holdings, … | OPRXOptimizeRx Corpor… |
|---|---|---|
| ROE (TTM)Return on equity | +4.8% | +4.2% |
| ROA (TTM)Return on assets | +1.9% | +3.0% |
| ROICReturn on invested capital | +13.0% | +7.1% |
| ROCEReturn on capital employed | +8.8% | +7.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.10x | 0.04x |
| Net DebtTotal debt minus cash | -$202M | -$19M |
| Cash & Equiv.Liquid assets | $262M | $23M |
| Total DebtShort + long-term debt | $60M | $5M |
| Interest CoverageEBIT ÷ Interest expense | 3.61x | 1.26x |
GDRX leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
GDRX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OPRX five years ago would be worth $1,266 today (with dividends reinvested), compared to $817 for GDRX. Over the past 12 months, GDRX leads with a -25.1% total return vs OPRX's -30.1%. The 3-year compound annual growth rate (CAGR) favors GDRX at -14.9% vs OPRX's -23.0% — a key indicator of consistent wealth creation.
| Metric | GDRXGoodRx Holdings, … | OPRXOptimizeRx Corpor… |
|---|---|---|
| YTD ReturnYear-to-date | +3.3% | -46.6% |
| 1-Year ReturnPast 12 months | -25.1% | -30.1% |
| 3-Year ReturnCumulative with dividends | -38.4% | -54.4% |
| 5-Year ReturnCumulative with dividends | -91.8% | -87.3% |
| 10-Year ReturnCumulative with dividends | -94.4% | +110.5% |
| CAGR (3Y)Annualised 3-year return | -14.9% | -23.0% |
GDRX leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
GDRX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GDRX is the less volatile stock with a 1.58 beta — it tends to amplify market swings less than OPRX's 2.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GDRX currently trades 48.9% from its 52-week high vs OPRX's 29.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | GDRXGoodRx Holdings, … | OPRXOptimizeRx Corpor… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.58x | 2.28x |
| 52-Week HighHighest price in past year | $5.81 | $22.25 |
| 52-Week LowLowest price in past year | $1.77 | $5.54 |
| % of 52W HighCurrent price vs 52-week peak | +48.9% | +29.8% |
| RSI (14)Momentum oscillator 0–100 | 66.1 | 46.9 |
| Avg Volume (50D)Average daily shares traded | 2.3M | 476K |
GDRX leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates GDRX as "Hold" and OPRX as "Buy". Consensus price targets imply 156.4% upside for OPRX (target: $17) vs 12.3% for GDRX (target: $3).
| Metric | GDRXGoodRx Holdings, … | OPRXOptimizeRx Corpor… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $3.19 | $17.00 |
| # AnalystsCovering analysts | 24 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 1 | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +21.3% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
GDRX leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). OPRX leads in 1 (Valuation Metrics).
Best OverallGoodRx Holdings, Inc. (GDRX)Leads 4 of 6 categories
Loading custom metrics...
GDRX vs OPRX: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is GDRX or OPRX a better buy right now?
For growth investors, OptimizeRx Corporation (OPRX) is the stronger pick with 18.
8% revenue growth year-over-year, versus 0. 6% for GoodRx Holdings, Inc. (GDRX). OptimizeRx Corporation (OPRX) offers the better valuation at 24. 6x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate OptimizeRx Corporation (OPRX) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GDRX or OPRX?
On trailing P/E, OptimizeRx Corporation (OPRX) is the cheapest at 24.
6x versus GoodRx Holdings, Inc. at 33. 3x. On forward P/E, OptimizeRx Corporation is actually cheaper at 7. 0x.
03Which is the better long-term investment — GDRX or OPRX?
Over the past 5 years, OptimizeRx Corporation (OPRX) delivered a total return of -87.
3%, compared to -91. 8% for GoodRx Holdings, Inc. (GDRX). Over 10 years, the gap is even starker: OPRX returned +110. 5% versus GDRX's -94. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GDRX or OPRX?
By beta (market sensitivity over 5 years), GoodRx Holdings, Inc.
(GDRX) is the lower-risk stock at 1. 58β versus OptimizeRx Corporation's 2. 28β — meaning OPRX is approximately 44% more volatile than GDRX relative to the S&P 500. On balance sheet safety, OptimizeRx Corporation (OPRX) carries a lower debt/equity ratio of 4% versus 10% for GoodRx Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GDRX or OPRX?
By revenue growth (latest reported year), OptimizeRx Corporation (OPRX) is pulling ahead at 18.
8% versus 0. 6% for GoodRx Holdings, Inc. (GDRX). On earnings-per-share growth, the picture is similar: OptimizeRx Corporation grew EPS 124. 5% year-over-year, compared to 104. 1% for GoodRx Holdings, Inc.. Over a 3-year CAGR, OPRX leads at 20. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GDRX or OPRX?
OptimizeRx Corporation (OPRX) is the more profitable company, earning 4.
7% net margin versus 3. 8% for GoodRx Holdings, Inc. — meaning it keeps 4. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GDRX leads at 13. 4% versus 10. 7% for OPRX. At the gross margin level — before operating expenses — GDRX leads at 82. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GDRX or OPRX more undervalued right now?
On forward earnings alone, OptimizeRx Corporation (OPRX) trades at 7.
0x forward P/E versus 9. 0x for GoodRx Holdings, Inc. — 1. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OPRX: 156. 4% to $17. 00.
08Which pays a better dividend — GDRX or OPRX?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is GDRX or OPRX better for a retirement portfolio?
For long-horizon retirement investors, GoodRx Holdings, Inc.
(GDRX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. OptimizeRx Corporation (OPRX) carries a higher beta of 2. 28 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GDRX: -94. 4%, OPRX: +110. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GDRX and OPRX?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: GDRX is a small-cap quality compounder stock; OPRX is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(GDRX: -4.4% · OPRX: -0.2%)Net Margin>
%
(GDRX: 3.7% · OPRX: 4.7%)P/E Ratio<
x
(GDRX: 33.3x · OPRX: 24.6x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.